Clinical trial
Study to Evaluate Safety, Tolerability and Fat Absorption Using a Novel Enteral Feeding In-line Digestive Enzyme Cartridge (RELIZORB) in Patients With Cystic Fibrosis Receiving Enteral Feeding
NCT02598128 is registered in ClinicalTrials.gov with Alcresta Therapeutics, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study to Evaluate Safety, Tolerability and Fat Absorption Using a Novel Enteral Feeding In-line Digestive Enzyme Cartridge (RELIZORB) in Patients With Cystic Fibrosis Receiving Enteral Feeding
- Lead sponsor
- Alcresta Therapeutics, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 30, 2015
- Completion date
- June 30, 2016
- Enrollment
- 34 (actual)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.